Source:http://linkedlifedata.com/resource/pubmed/id/10779803
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2000-5-22
|
pubmed:abstractText |
Polyclonal T cell lines specific for EBV proteins have proved efficient in preventing EBV-related immunoblastic lymphoma after allogeneic bone marrow transplantation. To gain insight into the composition of the EBV-specific T cell repertoire that ensured patient protection, we performed for the first time an extensive characterization of eight cytotoxic T cell lines selected in vitro against EBV-transformed autologous lymphoblastoid cell lines (BLCL). These T cell lines consist of 50-100 distinct T cell clones, of which 32-96% are specific for autologous BLCL. Moreover, we demonstrate that reactivities against only five EBV proteins (BZLF1, BMLF1, EBNA-3A, EBNA-3C, and LMP2) cover 86% (32/37) of the specificities detected. In addition, we describe an improved method of T cell harvesting using a CD25 selection procedure which reduces the time required to obtain specific T cells and improves the purity of EBV-specific T cells, thus showing promise for use in adoptive transfer protocols.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes, T-Lymphocyte,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Antigen, T-Cell...,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-2
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
164
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4924-32
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10779803-Adult,
pubmed-meshheading:10779803-Animals,
pubmed-meshheading:10779803-Antigens, Viral,
pubmed-meshheading:10779803-Cell Line, Transformed,
pubmed-meshheading:10779803-Cell Separation,
pubmed-meshheading:10779803-Cell Transformation, Viral,
pubmed-meshheading:10779803-Clone Cells,
pubmed-meshheading:10779803-Coculture Techniques,
pubmed-meshheading:10779803-Epitopes, T-Lymphocyte,
pubmed-meshheading:10779803-Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor,
pubmed-meshheading:10779803-Gene Rearrangement, beta-Chain T-Cell Antigen Receptor,
pubmed-meshheading:10779803-Herpesvirus 4, Human,
pubmed-meshheading:10779803-Humans,
pubmed-meshheading:10779803-Immunophenotyping,
pubmed-meshheading:10779803-Receptors, Antigen, T-Cell, alpha-beta,
pubmed-meshheading:10779803-Receptors, Interleukin-2,
pubmed-meshheading:10779803-T-Lymphocyte Subsets
|
pubmed:year |
2000
|
pubmed:articleTitle |
The T cell repertoire selected in vitro against EBV: diversity, specificity, and improved purification through early IL-2 receptor alpha-chain (CD25)-positive selection.
|
pubmed:affiliation |
Institut de Biologie, Institut National de la Santé et de la Recherche Médicale, Nantes, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|